Global Type-1 Diabetes Treatment Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Type-1 Diabetes Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Rapid-Acting Insulin
  • 1.4.3 Short-Acting Insulin
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Type-1 Diabetes Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals & Clinics
  • 1.5.3 Academic & Research Institutes
• 1.6 Coronavirus Disease 2019 (Covid-19): Type-1 Diabetes Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Type-1 Diabetes Treatment Industry
    • 1.6.1.1 Type-1 Diabetes Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Type-1 Diabetes Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Type-1 Diabetes Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Type-1 Diabetes Treatment Market Perspective (2015-2026)
• 2.2 Type-1 Diabetes Treatment Growth Trends by Regions
  • 2.2.1 Type-1 Diabetes Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Type-1 Diabetes Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Type-1 Diabetes Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Type-1 Diabetes Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Type-1 Diabetes Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Type-1 Diabetes Treatment Players by Market Size
  • 3.1.1 Global Top Type-1 Diabetes Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Type-1 Diabetes Treatment Market Concentration Ratio
  • 3.2.1 Global Type-1 Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Type-1 Diabetes Treatment Revenue in 2019
• 3.3 Type-1 Diabetes Treatment Key Players Head office and Area Served
• 3.4 Key Players Type-1 Diabetes Treatment Product Solution and Service
• 3.5 Date of Enter into Type-1 Diabetes Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Type-1 Diabetes Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2021-2026)

5 Type-1 Diabetes Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Type-1 Diabetes Treatment Market Size by Application (2015-2020)
• 5.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Type-1 Diabetes Treatment Market Size (2015-2020)
• 6.2 Type-1 Diabetes Treatment Key Players in North America (2019-2020)
• 6.3 North America Type-1 Diabetes Treatment Market Size by Type (2015-2020)
• 6.4 North America Type-1 Diabetes Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Type-1 Diabetes Treatment Market Size (2015-2020)
• 7.2 Type-1 Diabetes Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Type-1 Diabetes Treatment Market Size by Type (2015-2020)
• 7.4 Europe Type-1 Diabetes Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Type-1 Diabetes Treatment Market Size (2015-2020)
• 8.2 Type-1 Diabetes Treatment Key Players in China (2019-2020)
• 8.3 China Type-1 Diabetes Treatment Market Size by Type (2015-2020)
• 8.4 China Type-1 Diabetes Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Type-1 Diabetes Treatment Market Size (2015-2020)
• 9.2 Type-1 Diabetes Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Type-1 Diabetes Treatment Market Size by Type (2015-2020)
• 9.4 Japan Type-1 Diabetes Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Type-1 Diabetes Treatment Market Size (2015-2020)
• 10.2 Type-1 Diabetes Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Type-1 Diabetes Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Type-1 Diabetes Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Type-1 Diabetes Treatment Market Size (2015-2020)
• 11.2 Type-1 Diabetes Treatment Key Players in India (2019-2020)
• 11.3 India Type-1 Diabetes Treatment Market Size by Type (2015-2020)
• 11.4 India Type-1 Diabetes Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Type-1 Diabetes Treatment Market Size (2015-2020)
• 12.2 Type-1 Diabetes Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Type-1 Diabetes Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Type-1 Diabetes Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Astellas Pharma
  • 13.1.1 Astellas Pharma Company Details
  • 13.1.2 Astellas Pharma Business Overview and Its Total Revenue
  • 13.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction
  • 13.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2015-2020))
  • 13.1.5 Astellas Pharma Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview and Its Total Revenue
  • 13.2.3 Merck Type-1 Diabetes Treatment Introduction
  • 13.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 13.2.5 Merck Recent Development
• 13.3 Eli Lilly
  • 13.3.1 Eli Lilly Company Details
  • 13.3.2 Eli Lilly Business Overview and Its Total Revenue
  • 13.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction
  • 13.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 13.3.5 Eli Lilly Recent Development
• 13.4 Novo Nordisk
  • 13.4.1 Novo Nordisk Company Details
  • 13.4.2 Novo Nordisk Business Overview and Its Total Revenue
  • 13.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction
  • 13.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 13.4.5 Novo Nordisk Recent Development
• 13.5 Sanofi
  • 13.5.1 Sanofi Company Details
  • 13.5.2 Sanofi Business Overview and Its Total Revenue
  • 13.5.3 Sanofi Type-1 Diabetes Treatment Introduction
  • 13.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 13.5.5 Sanofi Recent Development
• 13.6 AstraZeneca
  • 13.6.1 AstraZeneca Company Details
  • 13.6.2 AstraZeneca Business Overview and Its Total Revenue
  • 13.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction
  • 13.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 13.6.5 AstraZeneca Recent Development
• 13.7 Boehringer Ingelheim GmbH
  • 13.7.1 Boehringer Ingelheim GmbH Company Details
  • 13.7.2 Boehringer Ingelheim GmbH Business Overview and Its Total Revenue
  • 13.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction
  • 13.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 13.7.5 Boehringer Ingelheim GmbH Recent Development
• 13.8 Novartis
  • 13.8.1 Novartis Company Details
  • 13.8.2 Novartis Business Overview and Its Total Revenue
  • 13.8.3 Novartis Type-1 Diabetes Treatment Introduction
  • 13.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 13.8.5 Novartis Recent Development
• 13.9 Pfizer Inc.
  • 13.9.1 Pfizer Inc. Company Details
  • 13.9.2 Pfizer Inc. Business Overview and Its Total Revenue
  • 13.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction
  • 13.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 13.9.5 Pfizer Inc. Recent Development
• 13.10 Abbott Laboratories
  • 13.10.1 Abbott Laboratories Company Details
  • 13.10.2 Abbott Laboratories Business Overview and Its Total Revenue
  • 13.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction
  • 13.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 13.10.5 Abbott Laboratories Recent Development
• 13.11 Mannkind Corporation
  • 10.11.1 Mannkind Corporation Company Details
  • 10.11.2 Mannkind Corporation Business Overview and Its Total Revenue
  • 10.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction
  • 10.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 10.11.5 Mannkind Corporation Recent Development
• 13.12 Braun Melsungen AG
  • 10.12.1 Braun Melsungen AG Company Details
  • 10.12.2 Braun Melsungen AG Business Overview and Its Total Revenue
  • 10.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction
  • 10.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 10.12.5 Braun Melsungen AG Recent Development
• 13.13 Macrogenics, Inc.
  • 10.13.1 Macrogenics, Inc. Company Details
  • 10.13.2 Macrogenics, Inc. Business Overview and Its Total Revenue
  • 10.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction
  • 10.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  • 10.13.5 Macrogenics, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer